Lisa N Akhtar1, Moriah L Szpara2. 1. Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 2. Department of Biochemistry and Molecular Biology, Center for Infectious Disease Dynamics, and the Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA.
Abstract
PURPOSE OF REVIEW: Neonatal infection by herpes simplex virus (HSV) 1 or 2 presents a devastating burden to new parents, due to the unpredictability of severe clinical outcomes, as well as the potential for lifelong reactivation. While just under half of neonatal HSV infections have mild clinical impacts akin to those observed in adults, the other half experience viral spread throughout the body (disseminated infection) and/or the brain (central nervous system infection). SUMMARY: Here we summarize current data on clinical diagnostic measures, antiviral therapy, and known factors of human host biology that contribute to the distinct neonatal outcomes of HSV infection. RECENT FINDINGS: We then explore recent new data on how viral genetic diversity between infections may impact clinical outcomes. Further research will be critical to build upon these early findings and to provide statistical power to our ability to discern and/or predict the potential clinical path of a given neonatal infection.
PURPOSE OF REVIEW: Neonatal infection by herpes simplex virus (HSV) 1 or 2 presents a devastating burden to new parents, due to the unpredictability of severe clinical outcomes, as well as the potential for lifelong reactivation. While just under half of neonatal HSV infections have mild clinical impacts akin to those observed in adults, the other half experience viral spread throughout the body (disseminated infection) and/or the brain (central nervous system infection). SUMMARY: Here we summarize current data on clinical diagnostic measures, antiviral therapy, and known factors of human host biology that contribute to the distinct neonatal outcomes of HSV infection. RECENT FINDINGS: We then explore recent new data on how viral genetic diversity between infections may impact clinical outcomes. Further research will be critical to build upon these early findings and to provide statistical power to our ability to discern and/or predict the potential clinical path of a given neonatal infection.
Entities:
Keywords:
Neonatal; comparative genomics; encephalitis; herpes simplex virus; human herpesvirus 1; human herpesvirus 2
Authors: Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey Journal: N Engl J Med Date: 1997-08-21 Impact factor: 91.245
Authors: Daniel P Depledge; Samit Kundu; Nancy J Jensen; Eleanor R Gray; Meleri Jones; Sharon Steinberg; Anne Gershon; Paul R Kinchington; D Scott Schmid; Francois Balloux; Richard A Nichols; Judith Breuer Journal: Mol Biol Evol Date: 2013-10-25 Impact factor: 16.240
Authors: Alexander L Greninger; Pavitra Roychoudhury; Hong Xie; Amanda Casto; Anne Cent; Gregory Pepper; David M Koelle; Meei-Li Huang; Anna Wald; Christine Johnston; Keith R Jerome Journal: mSphere Date: 2018-06-13 Impact factor: 4.389